Skip to main content
Log in

Subnormal secretion of parathyroid hormone prevents age-related bone loss

  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Parathyroid hormone (PTH) is a key factor involved in the systemic regulation of bone resorption. It is well known that a high turnover of bone occurred together with the reduced bone mass in patients with hyperparathyroidism. However, the effect of subnormal secretion of PTH on age-related bone loss has not been extensively investigated. Recently, some investigators and us have focused on the effect of suppressed PTH secretion and have demonstrated that patients with subnormal secretion of PTH preserved a relatively higher bone mineral densities than age- and sex-matched controls. We believe that these results will give a new insight into the mechanism of age-related bone loss or osteoporosis. Further studies are needed to evaluate the mechanisms of this protective effect of suppressed PTH secretion on bone mass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kotowicz MA, Klee GG, Kao PC et al.: Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type I osteoporosis: Evidence that skeletal sensitivity is increased. Osteoporosis Int 1: 14–22, 1990

    Article  CAS  Google Scholar 

  2. Cosman F, Shen V, Xie F et al.: Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Ann Intern Med 118: 337–343, 1993

    CAS  PubMed  Google Scholar 

  3. Selby PL, Peacock M: Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med 314: 1481–1485, 1986

    CAS  PubMed  Google Scholar 

  4. Jowsey J, Raisz LG: Experimental osteoporosis and parathyroid activity. Endocrinology 82: 384–396, 1968

    CAS  PubMed  Google Scholar 

  5. Barkhart JM, Jowsey J: Parathyroid and thyroid hormones in the development of immobilization osteoporosis. Endocrinology 81: 1053–1062, 1967

    Google Scholar 

  6. Bronsky D, Kushner DS, Dubin A et al.: Idiopathic hypoparathyroidism and pseudohypoparathyroidism: Case reports and review of the literattre. Medicine 37: 317–352, 1958

    CAS  PubMed  Google Scholar 

  7. Hossain M, Smith DA, Nordin BEC: Parathyroid activity and postmenopausal osteoporosis. Lancet I: 809–811, 1970

    Google Scholar 

  8. Seeman E, Wahner HW, Offord KP et al.: Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 69: 1302–1309, 1982

    CAS  PubMed  Google Scholar 

  9. Abugassa S, Nordenstrom J, Eriksson S et al.: Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 76: 1617–1621, 1993

    Article  CAS  PubMed  Google Scholar 

  10. Lehmke J, Bonger U, Felsenberg D et al.: Detamination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clin Endocrinol 36: 511–517, 1992

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Fujiyama, K., Kiriyama, T., Ito, M. et al. Subnormal secretion of parathyroid hormone prevents age-related bone loss. J Bone Miner Metab 12 (Suppl 1), S69–S70 (1994). https://doi.org/10.1007/BF02375678

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02375678

Key words

Navigation